Category Archives: MS Treatment

Kathy DeMellier appointed as Director of Admissions at The Pinnacle Schools in Huntsville Alabama. Ms. DeMellier will guide families through the selection and admission process of placing their troubled teen in a residential treatment program. Huntsville, Alabama (PRWEB) December 02, 2012 Ms. DeMellier was raised in Columbus, Ohio and later moved to Alabama where she has been residing for the past 26 years. She earned a Bachelors Degree in Social Work from Auburn University and later went on to earn her Masters Degree in Counseling. Since 1993, Kathy has worked with adolescents, their families and professionals in residential settings. She has served in varying roles in the residential programs including clinical, administrative and admissions.Kathy enjoys spending time with her family and friends, raising her daughter, painting and traveling. We are pleased to welcome Kathy and look forward to working with someone with such extensive experience, Ms. Lee said. The Pinnacle School Huntsville offers a blended learning model for instruction using an approved computer-based curriculum, highly qualified teachers in the classroom, and other supplements to allow students a self-paced instructional setting. Additionally, students are offered other services to promote learning and life skills development such as group counseling, anger management, coping … Continue reading →

Minnesota Wild goaltender Josh Harding is about to begin the fight of his life. Michael Russo of the Star Tribune reported Wednesday night that Harding has been diagnosed with multiple sclerosis, an incurable autoimmune disease in which the body randomly attacks and eats away the protective lining of his nerves and causes them to scar. It results in problems with balance, fatigue and blurred vision. Harding received the news approximately a month ago and has begun the process of informing friends and family, including Wild general manager Chuck Fletcher and coach Mike Yeo. Harding told the newspaper he has no plans of retiring. "I had a couple days where I felt bad for myself, but no more," Harding told Russo. "There's things in life that happen. Sometimes you can't explain it. You deal with it." Fletcher said, "Josh's competitive fire has led him to a successful career in the NHL and we know he will approach this new battle in the same manner." Harding began to feel something was wrong in September, when he was experiencing problems with his neck. An MRI exam revealed lesions on his brain, which led to the diagnosis. According to Russo, Harding has been put … Continue reading →

EDINA, MINN.Sitting on a white leather couch in the living room of his suburban Minneapolis home, Josh Harding doesnt get emotional as he tells his story. He looks completely healthy. He doesnt seem scared. He speaks so confidently, so courageously, youd never know his life has been altered forever. I dont look at this like Ive got to take a new path, said Harding, drafted 10 years ago by the Wild and months off signing a new three-year contract. This is a little bump in the road. Ive had lots in life. Harding, 28, has been diagnosed with multiple sclerosis, an incurable autoimmune disease in which the body randomly attacks and eats away the protective lining of his nerves and causes them to scar. It causes problems with balance, fatigue and blurred vision. There are 25,000 new cases diagnosed in the United States every year. I had a couple days where I felt bad for myself, but no more, said Harding, who plans on continuing his career. Theres things in life that happen. Sometimes you cant explain it. You deal with it. After keeping the disease private from everyone other than his immediate family for more than a month, Harding … Continue reading →

BRISTOL, England & HASSELT, Belgium--(BUSINESSWIRE)-- Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS). Receipt of the first dose of study treatment by the last patient to be recruited prompted an undisclosed clinical milestone payment from Merck Serono, a division of Merck, Germany, with whom Apitope is developing ATX-MS-1467. ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the entire immune system, and thus restore immunological balance. ATX-MS-1467 has already completed successfully a Phase I clinical trial in six patients with secondary progressive MS (SPMS). Based on these encouraging preliminary results, a second Phase I clinical trial has been implemented to assess the safety of ATX-MS-1467 as well as biological parameters in a group of 40patients with relapsing MS. The clinical trial is being carried out at two hospitals in the UK, as well as 12 clinics in Russia. Dosing of ATX-MS-1467 is expected to be complete by the … Continue reading →

The Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say it's shameful that Bill S-204 was squelched in committee. "This bill is dead, the Conservatives killed it," said Sen. Jim Munson. "Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law." The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. "They don't want to hear from MS patients, to have them as witnesses before the committee," said Sen. Jane Cordy, sponsor of the bill. "This is shameful." The Conservative senators argued this is a matter for science and medicine, not Parliament. "Since Day 1, the Conservatives have played politics with MS patients," Cordy said. The government has promised clinical trials of the therapy and a national register of patients, although neither the trials nor the registry have started. The bill … Continue reading →

OTTAWA The Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say its shameful that Bill S-204 was squelched in committee. This bill is dead, the Conservatives killed it, said Sen. Jim Munson. Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law. The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. They dont want to hear from MS patients, to have them as witnesses before the committee, said Sen. Jane Cordy, sponsor of the bill. This is shameful. The Conservative senators argued this is a matter for science and medicine, not Parliament. Since Day 1, the Conservative have played politics with MS patients, Cordy said. The Conservative senators on that committee threw the science away and have used politics, politics, politics. Cordy says as many as 75,000 Canadians suffer from … Continue reading →

OTTAWAThe Conservatives have used their Senate majority to kill legislation that would have authorized a national strategy to deal with a controversial therapy for multiple sclerosis. Liberal senators say its shameful that Bill S-204 was squelched in committee. This bill is dead, the Conservatives killed it, said Senator Jim Munson. Before we even got to clause by clause in this bill, the Conservative senators shut down the debate. They refused to allow a bill to go to clause by clause and thus go in to the Senate to become law. The Liberals said their Conservative opponents even refused to allow MS patients to testify about the effects of treatment for what is known as chronic cerebrospinal venous insufficiency or CCSVI. They dont want to hear from MS patients, to have them as witnesses before the committee, said Senator Jane Cordy, sponsor of the bill. This is shameful. The Conservative senators argued this is a matter for science and medicine, not Parliament. Since Day 1, the Conservative have played politics with MS patients, Cordy said. The Conservative senators on that committee threw the science away and have used politics, politics, politics. Cordy says as many as 75,000 Canadians suffer from MS. … Continue reading →

Advances in MS Treatment with Dr. Avasarala From:saintfranciscapeViews:4 0ratingsTime:01:03More inEducation Read more from the original source: Advances in MS Treatment with Dr. Avasarala - Video … Continue reading →

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company, (EURONEXT: SAN and NYSE: SNY) announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). The TGA approval will enable health professionals to prescribe AUBAGIO 14 mg in Australia, which is now the second country to gain marketing authorization for the treatment, following FDA approval in September. We are very pleased with the TGA approval of AUBAGIO that makes available a new option for healthcare professionals, and people living with MS in Australia who may benefit from this once-daily, oral treatment, said Bill Sibold, Head of Multiple Sclerosis, Genzyme. The availability of AUBAGIO in the U.S. and subsequent registration in Australia not only demonstrates our continued progress, it also reflects our commitment to deliver differentiated treatments and provide access for patients globally. The TGAs approval of AUBAGIO was based on safety and efficacy data from the TEMSO (TEriflunomide Multiple Sclerosis Oral) trial. The ongoing AUBAGIO clinical development program, involving more than 5,000 patients in 36 countries including Australia, is amongst the largest of any MS therapy. Some patients in extension trials have … Continue reading →

By Lucy Elkins PUBLISHED: 18:37 EST, 19 November 2012 | UPDATED: 11:59 EST, 20 November 2012 'I am a coper. I take each day as it comes,' said Janis Winehouse Janis Winehouse has had to face more than her fair share of tragedy. She watched as her singer daughter Amys rise to global superstardom was marred by drink and drug addiction, ending with her death in July last year at the age of 27. Last year took its toll physically and mentally, she says quietly. Yet Janis has her own battles to fight. For more than 30 years she has had multiple sclerosis (MS), and as her daughters life was spiralling out of control, Janiss health was taking a turn for the worse. Today, her right leg is so stiff she can only limp a few hundred yards at a time. Her memory is affected and she has also suffered with an overly sensitive bladder an embarrassing and debilitating part of MS, which causes incontinence. Originally posted here: Amy Winehouse's mother: How Botox helped her cope with her MS … Continue reading →